GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoString Technologies Inc (OTCPK:NSTGQ) » Definitions » Cyclically Adjusted PB Ratio

NanoString Technologies (NanoString Technologies) Cyclically Adjusted PB Ratio : 0.05 (As of May. 16, 2024)


View and export this data going back to 2013. Start your Free Trial

What is NanoString Technologies Cyclically Adjusted PB Ratio?

As of today (2024-05-16), NanoString Technologies's current share price is $0.1352. NanoString Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $2.50. NanoString Technologies's Cyclically Adjusted PB Ratio for today is 0.05.

The historical rank and industry rank for NanoString Technologies's Cyclically Adjusted PB Ratio or its related term are showing as below:

NSTGQ' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.02   Med: 4.57   Max: 43.56
Current: 0.04

During the past years, NanoString Technologies's highest Cyclically Adjusted PB Ratio was 43.56. The lowest was 0.02. And the median was 4.57.

NSTGQ's Cyclically Adjusted PB Ratio is ranked better than
98.28% of 466 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs NSTGQ: 0.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

NanoString Technologies's adjusted book value per share data for the three months ended in Sep. 2023 was $-1.051. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.50 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


NanoString Technologies Cyclically Adjusted PB Ratio Historical Data

The historical data trend for NanoString Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoString Technologies Cyclically Adjusted PB Ratio Chart

NanoString Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 22.02 3.46

NanoString Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.16 3.46 4.24 1.56 0.69

Competitive Comparison of NanoString Technologies's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, NanoString Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoString Technologies's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NanoString Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NanoString Technologies's Cyclically Adjusted PB Ratio falls into.



NanoString Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

NanoString Technologies's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.1352/2.5
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoString Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, NanoString Technologies's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-1.051/129.8595*129.8595
=-1.051

Current CPI (Sep. 2023) = 129.8595.

NanoString Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201312 2.152 98.326 2.842
201403 4.354 99.695 5.671
201406 3.638 100.560 4.698
201409 3.059 100.428 3.955
201412 2.453 99.070 3.215
201503 1.737 99.621 2.264
201506 1.752 100.684 2.260
201509 1.394 100.392 1.803
201512 1.033 99.792 1.344
201603 0.435 100.470 0.562
201606 0.017 101.688 0.022
201609 -0.329 101.861 -0.419
201612 0.572 101.863 0.729
201703 -0.141 102.862 -0.178
201706 2.067 103.349 2.597
201709 1.779 104.136 2.218
201712 1.578 104.011 1.970
201803 0.973 105.290 1.200
201806 0.334 106.317 0.408
201809 1.693 106.507 2.064
201812 1.193 105.998 1.462
201903 2.699 107.251 3.268
201906 2.431 108.070 2.921
201909 2.031 108.329 2.435
201912 2.869 108.420 3.436
202003 3.584 108.902 4.274
202006 3.023 108.767 3.609
202009 2.679 109.815 3.168
202012 6.907 109.897 8.162
202103 5.229 111.754 6.076
202106 4.829 114.631 5.471
202109 4.363 115.734 4.895
202112 3.870 117.630 4.272
202203 3.131 121.301 3.352
202206 2.424 125.017 2.518
202209 1.778 125.227 1.844
202212 0.981 125.222 1.017
202303 0.288 127.348 0.294
202306 -0.452 128.729 -0.456
202309 -1.051 129.860 -1.051

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NanoString Technologies  (OTCPK:NSTGQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


NanoString Technologies Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of NanoString Technologies's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoString Technologies (NanoString Technologies) Business Description

Traded in Other Exchanges
Address
530 Fairview Avenue North, Seattle, WA, USA, 98109
NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.
Executives
Jonathan Todd Garland officer: Chief Commercial Officer C/O CYTEK BIOSCIENCES, INC., 47215 LAKEVIEW BOULEVARD, FREMONT CA 94538
K Thomas Bailey officer: Chief Financial Officer 1618 STATION STREET, VANCOUVER A1 V6A 1B6
R Bradley Gray director, officer: President and CEO 530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109
William Young director 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Waite Charles P Jr director, 10 percent owner 11023 NE 116TH STREET, KIRKLAND WA 98034
Gregory Norden director 16640 CHESTERFIELD GROVE DRIVE, SUITE 200, CHESTERFIELD MO 63005
Elisha W Finney director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Teresa M. Foy director 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Joseph M Beechem officer: SVP, Research & Development 530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109
John D. Gerace officer: Chief Commercial Officer C/O NANOSTRING TECHNOLOGIES, INC., 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Kirk Malloy director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
J. Chad Brown officer: SVP, Sales & Marketing 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Robert Hershberg director 3005 FIRST AVENUE, SEATTLE WA 98121
Janet George director 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109
Dana E. Rollison director 530 FAIRVIEW AVENUE NORTH, SEATTLE WA 98109